Press "Enter" to skip to content

Pfizer’s weight loss pill, FDA rejects Novo’s weekly insulin, and FTC says drug middlemen are hiking prices: Pharma news round up

https://qz.com/pfizer-fda-novo-nordisk-ftc-1851588254
Pfizer said on Thursday that it is advancing development of a once-daily weight loss pill, which it believes could be competitive in the GLP-1 space. The U.S. Food and Drug Administration (FDA) did not approve Novo Nordisk’s once-weekly insulin. And the U.S. Federal Trade Commission (FTC) said in a report that…Read more…

More from BusinessMore posts in Business »
More from UncategorizedMore posts in Uncategorized »